Practice of pharmacy; certain drugs as over-the-counter; prescription; penalties; effective date.
Summary
HB1239 would amend Oklahoma pharmacy law to classify chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs. Under the bill, pharmacists and pharmacies could not require a prescription for the purchase of those medications.
The bill also creates a strong enforcement mechanism: if the State Board of Pharmacy determines that a pharmacist or pharmacy violated the new rule, the Board would be required to immediately revoke the license and impose a $100,000 fine for each occurrence. The act would take effect November 1, 2025.
Impact
The bill would add a new section to Title 59 of the Oklahoma Statutes governing pharmacy practice and would directly limit pharmacy discretion and existing prescription requirements for the three named drugs. It would also expand the State Board of Pharmacy’s enforcement role by mandating license revocation and substantial monetary penalties for noncompliance, affecting pharmacists, pharmacies, and consumers seeking these medications.
Sentiment
No committee transcript or vote record is available, so there is no documented debate or recorded sentiment from legislative proceedings. Based on the bill text alone, the measure appears designed to make access to the listed drugs easier, but it also imposes unusually severe penalties that suggest the proposal could draw both support from access advocates and concern from pharmacy regulators and professional groups.
Contention
The main point of contention is likely the bill’s treatment of chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs regardless of prescription status, which could conflict with standard medical and pharmacy practice. Another likely issue is the mandatory immediate license revocation and $100,000-per-occurrence fine, which may be viewed as excessively punitive by pharmacists, pharmacies, and the State Board of Pharmacy, while supporters may argue the penalties are necessary to ensure compliance and access.
Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.
Practice of pharmacy; requiring licensure of certain out-of-state pharmacies; requiring certain inspections; providing administrative remedies and penalties. Effective date.
Practice of pharmacy; authorizing product fulfillment through central fill pharmacies under certain conditions; authorizing shared services. Effective date.
Practice of nursing; providing for independent prescriptive authority of Advanced Practice Registered Nurses who meet certain requirements. Effective date.